Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of L-TAE with Farmorubicin and L-TAE with Adriamycin (second cooperative study)
Cancer Chemotherapy and Pharmacology1992Vol. 31(S1), pp. S20–S24
Citations Over Time
Jun Okamura, Saburo Kawai, Makoto Ogawa, Yasuo Ohashi, Masayoshi Tani, J. Inoue, Yoshifumi Kawarada, Mitsuo Kusano, Yasuhiko Kubo, C Kuroda, Yu Sakata, Y Shimamura, Kenji Jinno, Akira Takahashi, Kenichi Takayasu, Kazuo Tamura, Naofumi Nagasue, Yoshimi Nakanishi, M Makino, Manabu Masuzawa, S Mikuriya, Morito Monden, Yasuhiro Yumoto, Takesada Mori, Toshitsugu Oda, The Cooperative Study Group for Liver Cancer Treatment of Japan
Related Papers
- → Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus(2005)122 cited
- → Comparison of Clinical Characteristics and Survival after Surgery in Patients with Non-B and Non-C Hepatocellular Carcinoma and Hepatitis Virus-Related Hepatocellular Carcinoma(2013)33 cited
- → Comparative study of different interventional therapies for primary liver cancer(1997)1 cited
- The Anti-tumor Effect of Embolism with Heated Lipiodol for Hepatocarcinoma in V_2 Rabbits Model(2007)
- Observation of Long-time Effectiveness for Eradicating Helicobacter Pylori in Duodenal Ulcer Disease(2003)